Zobrazeno 1 - 10
of 55
pro vyhledávání: '"carbapenemasa"'
Autor:
Nancy Melgarejo Touchet, Sofía Busignani, Pamela Dunjo, Mariel Brítez, Aníbal Kawabata, Marlene Silvagni, Carolina Rojas, Eva Mereles, Evelyn López, Juana Salinas, Natalia Scavone, Karina Abreu, Jessy Colman, Betania Medina, Juan Irala, Stefan Goertzen, Vanesa López, Rosana Ortiz, Graciela Lird, Mario Martínez Mora
Publikováno v:
Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 19, Iss 3, Pp 35-43 (2021)
Las carbapenemasas se encuentran ampliamente distribuidas en nuestro país, tanto en bacilos gramnegativos fermentadores como no fermentadores. Durante 2021, se ha reportado incremento de cepas con estas enzimas. Con el objetivo de evaluar la doble p
Externí odkaz:
https://doaj.org/article/d175bab3325548c289e5a4a77afd838f
Autor:
Nancy Melgarejo-Touchet, Cristina Mariel Brítez, Sofía Busignani, Miryan Falcón, Evelyn López, Marcela Laconich, Raquel Blasco, Rocío Arguello, Anibal Kawabata, Martin Olmedo, Carolina Rojas, Marta González, Juana Salinas, Karina Abreu, Jazmín Pereira, Eva Mereles, Mario Martínez
Publikováno v:
Memorias del Instituto de Investigaciones en Ciencias de la Salud, Vol 19, Iss 2, Pp 49-58 (2021)
La resistencia a los antimicrobianos (RAM), representa un grave problema por el uso indiscriminado de antimicrobianos de amplio espectro. En nuestro país, durante el primer cuatrimestre del año, se observó un aumento inusual en el número de aisla
Externí odkaz:
https://doaj.org/article/c1061f8905334e10878ba014cf113349
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 35, Iss 2, Pp 259-64 (2018)
La diseminación global de carbapenemasas es de importancia en la salud pública. El objetivo del estudio es describir la presencia de genes de resistencia a carbapenémicos tipo KPC y metalobetalactamasas en enterobacterias aisladas de 12 hospitales
Externí odkaz:
https://doaj.org/article/dc2a08a9d6a948ae88fc6191f8237e02
Autor:
Cristhian Resurrección-Delgado, Juan José Montenegro-Idrogo, Alfredo Chiappe-Gonzalez, Renzo Vargas-Gonzales, Carolina Cucho-Espinoza, Dick Henry Mamani-Condori, Luz María Huaroto-Valdivia
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 34, Iss 2, Pp 261-7 (2017)
The emergence of Enterobacteria producing carbapenemases of type New Delhi Metalo beta-lactamases (NDM), represent, today, a real problem of world public health. The presence of this resistance mechanism limits or nullifies the therapeutic options to
Externí odkaz:
https://doaj.org/article/0293ccce1db54d3eb2b0a611afbd6f1a
Introducción/Objetivos Entre las distintas bacterias multirresistentes a antibióticos se encuentra Enterobacter cloacae, preocupante por su capacidad de adquirir carbapenemasas. Debido a esta inminente amenaza junto a la escasez de estudios, decidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1648::8466cc70b17efc27752accdfd9d63ae3
https://hdl.handle.net/10481/81344
https://hdl.handle.net/10481/81344
Autor:
Armindo Perozo-Mena, Maribel Castellanos-González, Eliana Ling, Liliana Gómez, Messaria Ginestre, Gresleida Rincón
Publikováno v:
Kasmera, Vol 44, Iss 1, Pp 44-52 (2016)
Klebsiella pneumoniae is an important opportunist pathogen that mainly cause outbreaks in health institutions, when it acquires the ability to produce carbapenemase, becomes resistant to betalactamics and other groups of antimicrobials as quinolones
Externí odkaz:
https://doaj.org/article/f45d652282144eb480a4e67d3564efcd
Autor:
Perozo-Mena Armindo, Castellanos-González Maribel, Ling Eliana, Gómez Liliana, Ginestre Messaria, Rincón Gresleida
Publikováno v:
Kasmera, Vol 44, Iss 1, Pp 44-52 (2016)
Abstract: Klebsiella pneumoniae is an important opportunist pathogen that mainly cause outbreaks in health institutions, when it acquires the ability to produce carbapenemase, becomes resistant to betalactamics and other groups of antimicrobials as q
Externí odkaz:
https://doaj.org/article/6114dfc7503d4c689e0838370f09d618
Publikováno v:
Revista Electrónica AnestesiaR; Vol. 14 Núm. 7 (2022): Revista Electrónica de AnestesiaR
A group of six infectious disease experts asked a series of common questions about the treatment of infections caused by Extended Spectrum β-lactamase producing Enterobacterales (ESBL-E), Carbapenem-resistant Enterobacterales (CRE), and Pseudomonas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=issn19899040::3fe5699787f98e1bcd8b3462f8238be1
http://revistaanestesiar.org/index.php/rear/article/view/1018
http://revistaanestesiar.org/index.php/rear/article/view/1018
Publikováno v:
Bush K. Past and present perspectives on β-lactamases. Vol. 62, Antimicrobial Agents and Chemotherapy. 2018. p. 1–20.
Queenan AM, Bush K. Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–58
Ovalle MV, Saavedra SY, González MN, Hidalgo AM, Duarte C, Beltrán M. Resultados de vigilancia nacional de la resistencia antimicrobiana. Biomedica. 2017;37:473–85.
Teo J, Cai Y, Lim T-P, Tan T, Kwa A. Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot. Microorganisms. 2016;4(1):13
salme, Timmusk. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL-producing Enterobacterales. Front Plant Sci. 2012;0954162(478):1–4.
Vasoo S, Barreto JN, Tosh PK. Emerging Issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician. Mayo Clin Proc [Internet]. 2015;90(3):395–403. Available from: http://dx.doi.org/10.1016/j.mayocp.2014.12.002
Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24(1):1–12.
Villegas MV, Jiménez A, Esparza G, Appel TM. Carbapenemase-producing Enterobacteriaceae: A diagnostic, epidemiological and therapeutic challenge. Infectio. 2019;23(4):388–98.
Vasiliki Tsolaki, a Konstantinos Mantzarlis, a Athanasios Mpakalis, a Ergina Malli, b Fotios Tsimpoukas, c Athanasia Tsirogianni, c Constantinos Papagiannitsis, b Paris 36 Zygoulis, a Maria-Eirini Papadonta, a Efthimia Petinaki, b Demosthenes Makris a EZ. crossm Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically. 2020;64(3):1–11.
Yee R, Dien Bard J, Simner PJ. The Genotype to Phenotype Dilemma: How Should Laboratories Approach Discordant Susceptibility Results? J Clin Microbiol. 2021;(January)
Logan LK, Weinstein RA. The epidemiology of Carbapenem-resistant enterobacteriaceae: The impact and evolution of a global menace. J Infect Dis. 2017;215(Suppl 1):S28–36.
Zhu Y, Huang WE, Yang Q. Clinical Perspective of Antimicrobial Resistance in Bacteria. Infect Drug Resist. 2022;15(March):735–46.
Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents [Internet]. 2017;50(2):127– 34. Available from: http://dx.doi.org/10.1016/j.ijantimicag.2017.03.012
Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;609–16
Lynch JP, Zhanel GG, Clark NM. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options. Semin Respir Crit Care Med. 2017;38(3):311–25
Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics. 2019;8(2)
INS. Informe De Resultados De La Vigilancia Por Laboratorio De Resistencia Antimicrobiana En Infecciones Asociadas a La Atención En Salud (Iaas) 2018 Dirección. Epidemiol las Infecc Asoc a la atención en salud. 2019;29–44.
Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50(8):2880–2.
Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553–5.
Boyd SE, Livermore DM, Hooper DC, Hope WW. Metallo-β-lactamases: Structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. 2020;64(10):1–20.
Rojo V, Vázquez P, Reyes S, Fuertes LP, Cervero M. Risk factors and clinical evolution of carbapenemase-producing klebsiella pneumoniae infections in a university hospital in Spain. Case-control study. Rev Esp Quimioter. 2018;31(5):427–34.
Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant enterobacteriaceae: A strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38(5):580–94.
Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1).
Sze DTT, Lau CCY, Chan TM, Ma ESK, Tang BSF. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels. BMC Microbiol [Internet]. 2021;21(1):1–15. Available from: https://doi.org/10.1186/s12866-021-02403-y
Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson JK, et al. Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin Microbiol. 2016;54(3):687–98.
Schneider JG, Wood JB, Schmitt BH, Emery CL, Davis TE, Smith NW, et al. Susceptibility Provision Enhances Effective De-escalation (SPEED): Utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother. 2019;74:I16–23.
Bassetti M, Peghin M. How to manage KPC infections. Ther Adv Infect Dis. 2020;7:1–12.
Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(SUPPL. 2):82–9.
Association WM. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013 Sep 22;310(20):2191–4.
Ministerio de salud. RESOLUCION NUMERO 8430 DE 1993. Minsterio de salud. 1993;1–19.
Sotgiu G, Are BM, Pesapane L, Palmieri A, Muresu N, Cossu A, et al. Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study. J Hosp Infect [Internet]. 2018;99(4):413–8. Available from: https://doi.org/10.1016/j.jhin.2018.03.033
Gupta N, Limbago BM, Patel JB, Kallen AJ, Sotgiu G, Are BM, et al. Carbapenem-resistant enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis [Internet]. 2018;53(4):413–8. Available from: https://doi.org/10.1016/j.jhin.2018.03.033
Kunz Coyne AJ, El Ghali A, Holger D, Rebold N, Rybak MJ. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infect Dis Ther [Internet]. 2022;11(2):661–82. Available from: https://doi.org/10.1007/s40121-022-00591-2
Esparza G. Bacterias Gram negativas resistentes a carbapenemicos en Colombia: un desafío continuo al sistema de salud. Infectio. 2020;24(2):55–6.
Marco F. Métodos moleculares para el diagnóstico de septicemia. Enferm Infecc Microbiol Clin. 2017;35(9):586–92.
Salomão MC, Guimarães T, Duailibi DF, Perondi MBM, Letaif LSH, Montal AC, et al. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hosp Infect.
Remolina S, Escobar C. DESCRIPCIÓN DE TIPOS DE CARBAPENEMASAS EXPRESADAS EN Klebsiella sp. y Pseudomonas aeruginosa EN HOSPITALES DE TERCER NIVEL DE LA CIUDAD DE BOGOTÁ, ESTUDIO DESCRIPTIVO. Univ Nac Colomb. 2018
Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018;56(11):1–13.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Queenan AM, Bush K. Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–58
Ovalle MV, Saavedra SY, González MN, Hidalgo AM, Duarte C, Beltrán M. Resultados de vigilancia nacional de la resistencia antimicrobiana. Biomedica. 2017;37:473–85.
Teo J, Cai Y, Lim T-P, Tan T, Kwa A. Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot. Microorganisms. 2016;4(1):13
salme, Timmusk. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL-producing Enterobacterales. Front Plant Sci. 2012;0954162(478):1–4.
Vasoo S, Barreto JN, Tosh PK. Emerging Issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician. Mayo Clin Proc [Internet]. 2015;90(3):395–403. Available from: http://dx.doi.org/10.1016/j.mayocp.2014.12.002
Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020;24(1):1–12.
Villegas MV, Jiménez A, Esparza G, Appel TM. Carbapenemase-producing Enterobacteriaceae: A diagnostic, epidemiological and therapeutic challenge. Infectio. 2019;23(4):388–98.
Vasiliki Tsolaki, a Konstantinos Mantzarlis, a Athanasios Mpakalis, a Ergina Malli, b Fotios Tsimpoukas, c Athanasia Tsirogianni, c Constantinos Papagiannitsis, b Paris 36 Zygoulis, a Maria-Eirini Papadonta, a Efthimia Petinaki, b Demosthenes Makris a EZ. crossm Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically. 2020;64(3):1–11.
Yee R, Dien Bard J, Simner PJ. The Genotype to Phenotype Dilemma: How Should Laboratories Approach Discordant Susceptibility Results? J Clin Microbiol. 2021;(January)
Logan LK, Weinstein RA. The epidemiology of Carbapenem-resistant enterobacteriaceae: The impact and evolution of a global menace. J Infect Dis. 2017;215(Suppl 1):S28–36.
Zhu Y, Huang WE, Yang Q. Clinical Perspective of Antimicrobial Resistance in Bacteria. Infect Drug Resist. 2022;15(March):735–46.
Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents [Internet]. 2017;50(2):127– 34. Available from: http://dx.doi.org/10.1016/j.ijantimicag.2017.03.012
Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019;609–16
Lynch JP, Zhanel GG, Clark NM. Infections Due to Acinetobacter baumannii in the ICU: Treatment Options. Semin Respir Crit Care Med. 2017;38(3):311–25
Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics. 2019;8(2)
INS. Informe De Resultados De La Vigilancia Por Laboratorio De Resistencia Antimicrobiana En Infecciones Asociadas a La Atención En Salud (Iaas) 2018 Dirección. Epidemiol las Infecc Asoc a la atención en salud. 2019;29–44.
Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50(8):2880–2.
Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553–5.
Boyd SE, Livermore DM, Hooper DC, Hope WW. Metallo-β-lactamases: Structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. 2020;64(10):1–20.
Rojo V, Vázquez P, Reyes S, Fuertes LP, Cervero M. Risk factors and clinical evolution of carbapenemase-producing klebsiella pneumoniae infections in a university hospital in Spain. Case-control study. Rev Esp Quimioter. 2018;31(5):427–34.
Friedman ND, Carmeli Y, Walton AL, Schwaber MJ. Carbapenem-resistant enterobacteriaceae: A strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38(5):580–94.
Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1).
Sze DTT, Lau CCY, Chan TM, Ma ESK, Tang BSF. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels. BMC Microbiol [Internet]. 2021;21(1):1–15. Available from: https://doi.org/10.1186/s12866-021-02403-y
Salimnia H, Fairfax MR, Lephart PR, Schreckenberger P, DesJarlais SM, Johnson JK, et al. Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin Microbiol. 2016;54(3):687–98.
Schneider JG, Wood JB, Schmitt BH, Emery CL, Davis TE, Smith NW, et al. Susceptibility Provision Enhances Effective De-escalation (SPEED): Utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother. 2019;74:I16–23.
Bassetti M, Peghin M. How to manage KPC infections. Ther Adv Infect Dis. 2020;7:1–12.
Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(SUPPL. 2):82–9.
Association WM. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013 Sep 22;310(20):2191–4.
Ministerio de salud. RESOLUCION NUMERO 8430 DE 1993. Minsterio de salud. 1993;1–19.
Sotgiu G, Are BM, Pesapane L, Palmieri A, Muresu N, Cossu A, et al. Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study. J Hosp Infect [Internet]. 2018;99(4):413–8. Available from: https://doi.org/10.1016/j.jhin.2018.03.033
Gupta N, Limbago BM, Patel JB, Kallen AJ, Sotgiu G, Are BM, et al. Carbapenem-resistant enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis [Internet]. 2018;53(4):413–8. Available from: https://doi.org/10.1016/j.jhin.2018.03.033
Kunz Coyne AJ, El Ghali A, Holger D, Rebold N, Rybak MJ. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infect Dis Ther [Internet]. 2022;11(2):661–82. Available from: https://doi.org/10.1007/s40121-022-00591-2
Esparza G. Bacterias Gram negativas resistentes a carbapenemicos en Colombia: un desafío continuo al sistema de salud. Infectio. 2020;24(2):55–6.
Marco F. Métodos moleculares para el diagnóstico de septicemia. Enferm Infecc Microbiol Clin. 2017;35(9):586–92.
Salomão MC, Guimarães T, Duailibi DF, Perondi MBM, Letaif LSH, Montal AC, et al. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. J Hosp Infect.
Remolina S, Escobar C. DESCRIPCIÓN DE TIPOS DE CARBAPENEMASAS EXPRESADAS EN Klebsiella sp. y Pseudomonas aeruginosa EN HOSPITALES DE TERCER NIVEL DE LA CIUDAD DE BOGOTÁ, ESTUDIO DESCRIPTIVO. Univ Nac Colomb. 2018
Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol. 2018;56(11):1–13.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La resistencia a carbapenémicos por bacterias gram negativas, supone una pérdida importante de medicamentos de ultima línea para su manejo. Adicionalmente, los métodos diagnósticos actuales para la identificación de estos mecanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8df3152cf59485d7f28424c64904be
https://repository.urosario.edu.co/handle/10336/34666
https://repository.urosario.edu.co/handle/10336/34666
Autor:
Esther Culebras, Adela Alvarez-Buylla, Cristina García-Salguero, Iciar Rodríguez-Avial, Alberto Delgado-Iribarren
Publikováno v:
Revista Española de Quimioterapia
espanolObjetivo. Evaluar la capacidad de MALDI-TOF MS (Matrixassisted Laser Desorption-Ionization Time Of Flight) y rep-PCR para discriminar diferentes clones de Acinetobacter baumannii. Material y metodos. Se incluyeron en el estudio 21 aislados de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55058709d11e1899cd97d3b3e4894889
https://doi.org/10.37201/req/142.2020
https://doi.org/10.37201/req/142.2020